Molecular diagnosis and precision medicine in allergy management

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 11, 2016, Pages 1705-1714

  Riccio, Anna Maria ^a   De Ferrari, Laura ^a   Chiappori, Alessandra ^a   Ledda, Sabina ^a   Passalacqua, Giovanni ^a   Melioli, Giovanni ^a   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

allergen immunotherapy; computer supported allergy diagnostics; molecular based allergen diagnostics; multiplexed allergy diagnosis; precision medicine; singleplexed allergy diagnosis

Indexed keywords

60S ACIDIC RIBOSOMAL PROTEIN; ALLERGEN; ALPHA CASEIN; AMYLASE; ATP GUANIDO PHOSPHOTRANSFERASE; BET V 1 RELATED PROTEIN; BETA CASEIN; CLASS I CHITINASE; CRISPR ASSOCIATED PROTEIN; CUPIN SUPERFAMILY; EF HAND DOMAIN; ENOLASE; EUKARYOTIC ASPARTYL PROTEASE; GLOBIN; HEVEIN LIKE DOMAIN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; LIPOCALIN; PAPAIN LIKE CYSTEINE PROTEINASE; PATULIN; POLYGALACTURONASE; PROFILIN; PROLAMIN; SERUM ALBUMIN; SUBTILISIN LIKE SERINE PROTEASE; THAUMATIN LIKE PROTEIN; THIOREDOXIN; TRIACYLGLYCEROL LIPASE; TROPOMYOSIN; TRYPTASE; UNCLASSIFIED DRUG;

ALLERGY; ALLERGY RAPID TEST; ALLERGY TEST; COMPUTER ASSISTED DIAGNOSIS; CONFERENCE PAPER; GRASS POLLEN; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LABORATORY TEST; MEDICAL HISTORY; MOLECULAR DIAGNOSIS; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SENSITIZATION; DESENSITIZATION; HYPERSENSITIVITY;

DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; PRECISION MEDICINE;

EID: 84991289612     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2016-0007     Document Type: Conference Paper

References (56)

1. Adams JU. Genetics: Big hopes for big data. Nature 2015;527:S108-9.
2. Ozdemir V, Dove ES, Gursoy UK, Sardas S, Yildirim A, Yilmaz SG, et al. Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome. J Neural Transm (Vienna) 2015. [Epub ahead of print].
3. Kass-Hout TA, Xu Z, Mohebbi M, Nelsen H, Baker A, Levine J, et al. OpenFDA: an innovative platform providing access to a wealth of FDA s publicly available data. J Am Med Inform Assoc 2015.
4. Reeves D, Blickem C, Vassilev I, Brooks H, Kennedy A, Richardson G, et al. The contribution of social networks to the health and self-management of patients with long-Term conditions: a longitudinal study. PLoS One 2014;9:e98340.
5. Jameson JL, Longo DL. Precision medicine-personalized, problematic, and promising. N Engl J Med 2015;372:2229-34.
6. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372:793-5.
7. Jimenez-Sanchez G. Genomics innovation: transforming healthcare, business, and the global economy. Genome 2015;58:511-7.
8. Aronson N. Making personalized medicine more affordable. Ann NY Acad Sci 2015;1346:81-9.
9. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716-25.
10. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy 2012;42:650-8.
11. Ray A, Oriss TB, Wenzel SE. Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol 2015;308:L130-40.
12. Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO-ARIA-GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013;6:17.
13. Melioli G, Canonica GW. Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol 2012;108:387.
14. Melioli G, Passalacqua G, Canonica GW. Novel in silico technology in combination with microarrays: a state-of-The-Art technology for allergy diagnosis and management? Expert Rev Clin Immunol 2014;10:1559-61.
15. Finkelstein J, Wood J. Predicting asthma exacerbations using artificial intelligence. Stud Health Technol Inform 2013;190:56-8.
16. Melioli G, Spenser C, Reggiardo G, Passalacqua G, Compalati E, Rogkakou A, et al. Allergenius, an expert system for the interpretation of allergen microarray results. World Allergy Organ J 2014;7:15.
17. Pali-Scholl I, Jensen-Jarolim E. Anti-Acid medication as a risk factor for food allergy. Allergy 2011;66:469-77.
18. Melioli G, Compalati E, Bonini S, Canonica GW. The added value of allergen microarray technique to the management of poly-sensitized allergic patients. Curr Opin Allergy Clin Immunol 2012;12:434-9.
19. Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol 1966;97:75-85.
20. Johansson SG. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967;2:951-3.
21. Valenta R, Duchene M, Vrtala S, Birkner T, Ebner C, Hirschwehr R, et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol 1991;88:889-94.
22. Douladiris N, Savvatianos S, Roumpedaki I, Skevaki C, Mitsias D, Papadopoulos NG. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards componentresolved management of allergic diseases. Int Arch Allergy Immunol 2013;162:163-72.
23. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414-6.
24. Melioli G, Bonifazi F, Bonini S, Maggi E, Mussap M, Passalacqua G, et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem 2011;44:1005-11.
25. Melioli G, Marcomini L, Agazzi A, Bazurro G, Tosca M, Rossi GA, et al. The IgE repertoire in children and adolescents resolved at component level: a cross-sectional study. Pediatr Allergy Immunol 2012;23:433-40.
26. Melioli G, Passalacqua G, Canonica GW, Baena-Cagnani CE, Matricardi P. Component-resolved diagnosis in pediatric allergic rhinoconjunctivitis and asthma. Curr Opin Allergy Clin Immunol 2013;13:446-51.
27. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergenchip. Methods 2014;66:106-19.
28. Williams P, Onell A, Baldracchini F, Hui V, Jolles S, El-Shanawany T. Evaluation of a novel automated allergy microarray platform compared with three other allergy test methods. Clin Exp Immunol 2015.
29. Incorvaia C, Mauro M, Ridolo E, Makri E, Montagni M, Ciprandi G. A pitfall to avoid when using an allergen microarray: the incidental detection of IgE to unexpected allergens. J Allergy Clin Immunol Pract 2015;3:879-82.
30. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009;64(Suppl 91):1-59.
31. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.
32. Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009;103:451-59; quiz 9-61, 95.
33. Santos A, Van Ree R. Profilins: mimickers of allergy or relevant allergens? Int Arch Allergy Immunol 2011;155:191-204.
34. Passalacqua G, Melioli G, Bonifazi F, Bonini S, Maggi E, Senna G, et al. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy 2013;68:1029-33.
35. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 2012;67:709-11.
36. Sastre J, Rodriguez F, Campo P, Laffond E, Marin A, Alonso MD. Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy 2015;70:598-600.
37. Schmid-Grendelmeier P. [Pollen allergy and immunotherapy]. Ther Umsch 2012;69:239-48.
38. Schmid-Grendelmeier P. [Recombinant allergens. For routine use or still only science?]. Hautarzt 2010;61:946-53.
39. Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012;130:894-901 e5.
40. Stringari G, Tripodi S, Caffarelli C, Dondi A, Asero R, Di Rienzo Businco A, et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol 2014;134:75-81.
41. Tripodi S, Frediani T, Lucarelli S, Macri F, Pingitore G, Di Rienzo Businco A, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol 2012;129:834-9 e8.
42. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-13.
43. Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-Allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008;122:951-60.
44. Bachert C, Larche M, Bonini S, Canonica GW, Kundig T, Larenas-Linnemann D, et al. Allergen immunotherapy on the way to product-based evaluation-A WAO statement. World Allergy Organ J 2015;8:29.
45. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013;131:1288-96 e3.
46. Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 2014;7:6.
47. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy 2011;41:1201-20.
48. Passalacqua G. Specific immunotherapy in asthma: a comprehensive review. J Asthma 2014;51:29-33.
49. Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases. Allergo J Int 2014;23:282-319.
50. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-32.
51. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133:599-609.
52. Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics 2013;131:1155-67.
53. Lu Y, Xu L, Xia M, Li Y, Cao L. The efficacy and safety of subcutaneous immunotherapy in mite-sensitized subjects with asthma: a meta-Analysis. Respir Care 2015;60:269-78.
54. Canonica GW, Bachert C, Hellings P, Ryan D, Valovirta E, Wickman M, et al. Allergen Immunotherapy (AIT): a prototype of Precision Medicine. World Allergy Organ J 2015;8:31.
55. Passalacqua G, Canonica GW. AIT (allergen immunotherapy): a model for the "precision medicine." Clin Mol Allergy 2015;13:24.
56. Macchia D, Melioli G, Pravettoni V, Nucera E, Piantanida M, Caminati M, et al. Guidelines for the use and interpretation of diagnostic methods in adult food allergy. Clin Mol Allergy 2015;13:27.